Heart failure across Asia: Same healthcare burden but differences in organization of care

© 2016 The Authors A gap in the knowledge on the status of heart failure (HF) in Asia versus other regions led to the creation of a working group of Asian experts from 9 countries or regions (Hong Kong, Indonesia, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam). Each ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Reyes E., Ha J., Firdaus I., Ghazi A., Phrommintikul A., Sim D., Vu Q., Siu C., Yin W., Cowie M.
Format: Journal
Published: 2017
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84981731619&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/41342
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University
id th-cmuir.6653943832-41342
record_format dspace
spelling th-cmuir.6653943832-413422017-09-28T04:20:41Z Heart failure across Asia: Same healthcare burden but differences in organization of care Reyes E. Ha J. Firdaus I. Ghazi A. Phrommintikul A. Sim D. Vu Q. Siu C. Yin W. Cowie M. © 2016 The Authors A gap in the knowledge on the status of heart failure (HF) in Asia versus other regions led to the creation of a working group of Asian experts from 9 countries or regions (Hong Kong, Indonesia, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam). Each expert sought the best available data from local publications, registries, or clinical practice. The prevalence of HF in Asia was generally similar to global values (1% to 3%), but with some outliers. There were substantial variations in healthcare spending, and the average cost of HF hospitalization varied from 813 US$ in Indonesia to nearly 9000 US$ in South Korea. Comorbidities were frequent, particularly hypertension, diabetes mellitus, and dyslipidemia. Modifiable risk factors such as smoking were alarmingly common in some countries. Asian HF patients spent between 5 and 12.5 days in hospital, and 3% to 15% were readmitted for HF by 30 days. The pharmacological treatment of Asian patients generally followed international guidelines, including renin–angiotensin–aldosterone system inhibitors (61% to 90%), diuretics (76% to 99%), beta-blockers (32% to 78%), and digoxin (19% to 53%), with some room for improvement in terms of life-saving therapies. Our review supports implementation of a more comprehensive and organized approach to HF care in Asia. 2017-09-28T04:20:41Z 2017-09-28T04:20:41Z 2016-11-15 Journal 01675273 2-s2.0-84981731619 10.1016/j.ijcard.2016.07.256 https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84981731619&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/41342
institution Chiang Mai University
building Chiang Mai University Library
country Thailand
collection CMU Intellectual Repository
description © 2016 The Authors A gap in the knowledge on the status of heart failure (HF) in Asia versus other regions led to the creation of a working group of Asian experts from 9 countries or regions (Hong Kong, Indonesia, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam). Each expert sought the best available data from local publications, registries, or clinical practice. The prevalence of HF in Asia was generally similar to global values (1% to 3%), but with some outliers. There were substantial variations in healthcare spending, and the average cost of HF hospitalization varied from 813 US$ in Indonesia to nearly 9000 US$ in South Korea. Comorbidities were frequent, particularly hypertension, diabetes mellitus, and dyslipidemia. Modifiable risk factors such as smoking were alarmingly common in some countries. Asian HF patients spent between 5 and 12.5 days in hospital, and 3% to 15% were readmitted for HF by 30 days. The pharmacological treatment of Asian patients generally followed international guidelines, including renin–angiotensin–aldosterone system inhibitors (61% to 90%), diuretics (76% to 99%), beta-blockers (32% to 78%), and digoxin (19% to 53%), with some room for improvement in terms of life-saving therapies. Our review supports implementation of a more comprehensive and organized approach to HF care in Asia.
format Journal
author Reyes E.
Ha J.
Firdaus I.
Ghazi A.
Phrommintikul A.
Sim D.
Vu Q.
Siu C.
Yin W.
Cowie M.
spellingShingle Reyes E.
Ha J.
Firdaus I.
Ghazi A.
Phrommintikul A.
Sim D.
Vu Q.
Siu C.
Yin W.
Cowie M.
Heart failure across Asia: Same healthcare burden but differences in organization of care
author_facet Reyes E.
Ha J.
Firdaus I.
Ghazi A.
Phrommintikul A.
Sim D.
Vu Q.
Siu C.
Yin W.
Cowie M.
author_sort Reyes E.
title Heart failure across Asia: Same healthcare burden but differences in organization of care
title_short Heart failure across Asia: Same healthcare burden but differences in organization of care
title_full Heart failure across Asia: Same healthcare burden but differences in organization of care
title_fullStr Heart failure across Asia: Same healthcare burden but differences in organization of care
title_full_unstemmed Heart failure across Asia: Same healthcare burden but differences in organization of care
title_sort heart failure across asia: same healthcare burden but differences in organization of care
publishDate 2017
url https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84981731619&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/41342
_version_ 1681421984429244416